The measurement of patient attitudes regarding prenatal and preconception genetic carrier screening and translational behavioral medicine: an integrative review
Tóm tắt
Measurement of recessive carrier screening attitudes related to conception and pregnancy is necessary to determine current acceptance, and whether behavioral intervention strategies are needed in clinical practice. To evaluate quantitative survey instruments to measure patient attitudes regarding genetic carrier testing prior to conception and pregnancy databases examining patient attitudes regarding genetic screening prior to conception and pregnancy from 2003–2013 were searched yielding 344 articles; eight studies with eight instruments met criteria for inclusion. Data abstraction on theoretical framework, subjects, instrument description, scoring, method of measurement, reliability, validity, feasibility, level of evidence, and outcomes was completed. Reliability information was provided in five studies with an internal consistency of Cronbach’s α >0.70. Information pertaining to validity was presented in three studies and included construct validity via factor analysis. Despite limited psychometric information, these questionnaires are self-administered and can be briefly completed, making them a feasible method of evaluation.
Tài liệu tham khảo
Mennuti M. Genetic screening in reproductive health care. Clin Obstet Gynecol. 2008; 51(1): 3-23. doi:10.1097/GRF.0b013e318160f241.
Finer L, Zolna M. Shifts in intended and unintended pregnancies in the United States, 2001–2008. Am J Public Health. 2014; 104(S1): S44-S48.
Srinivasan B, Evans E, Flannick J, et al. A universal carrier test for the long tail of Mendelian disease. Reprod Biomed Online. 2010; 21: 537-551. doi:10.1016/j.rbmo.2010.05.012.
National Heart, Lung, and Blood Institute. Cystic fibrosis. NIH. 1995; Pub.No.95-3650. http://www.cdc.gov/excite/ScienceAmbassador/ambassadorpgm/lessonplans/high_school/Am%20I%20a%20Carrier%20for%20Cystic%20Fibrosis/Cystic_Fibrosis_Fact_Sheet.pdf
Williamson R. Universal community carrier screening for cystic fibrosis? Nat Genet. 1993; 3: 195-201.
Borry P, Henneman L, Lakeman P, ten Kate LP, Cornel M, Howard HC. Preconceptional genetic carrier testing and the commercial offer directly-to-consumers. Hum Reprod. 2011; 26(5): 972-977. doi:10.1093/humrep/der042.
Rappaport VJ. Prenatal diagnosis and genetic screening—integration into prenatal care. Obstet Gynecol Clin N Am. 2008; 35(3): 435-458.
National Institutes of Health. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development. Conference statement on genetic testing for cystic fibrosis. Arch Int Med. 1999; 159: 1529-1539.
Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med. 2001; 3: 149-154.
Haddow J, Palomaki G, eds. Population-based prenatal screening for cystic fibrosis via carrier testing: ACCE review. 2010. www.cdc.gov/genomics/activities/FBR/ACCE.htm. Accessed July 1, 2013
About Counsyl. Counsyl Web site. http://www.counsyl.com/about/counsyl. 2013. Accessed June 10, 2013.
Burke W, Tarini B, Press NA, Evans JP. Genetic screening. Epidemiol Rev. 2011; 33(1): 148-164. doi:10.1093/epirev/mxr008.
Bell CJ, Dinwiddie DL, Miller NA, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med. 2011; 3(65): 65ra4. doi:10.1126/scitranslmed.3001756.
Kaback MM. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. Eur J Pediatr. 2000; 159: S192-S195.
Mennuti MT. Genetic screening in reproductive health care. Clin Obstet Gynecol. 2008; 51(1): 3-23.
Metcalfe SA. Carrier screening in preconception consultation in primary care. J Commun Genet. 2012; 3: 193-203. doi:10.1007/s12687-011-0071-z.
"attitude". Oxford Dictionaries. Oxford University Press, n.d. http://oxforddictionaries.com/us/definition/american_english/attitude. Accessed June 07, 2013.
Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991; 50(2): 179-211.
Cooke R, French DP. How well do the theory of reasoned action and theory of planned behavior predict intentions and attendance at screening programmes? A meta-analysis. Psychol Health. 2008; 23: 745-765.
Botoseneau A, Alexander JA, Banaszak-Holl J. To test or not to test? The role of attitudes, knowledge, and religious involvement among U.S. adults on intent-to-obtain adult genetic testing. Health Educ Behav. 2011; 38: 617. doi:10.1177/1090198110389711.
Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005; 52(5): 546-553.
Fitzpatrick-Lewis D, Thomas H, Ciliska D. The methods for the synthesis of studies without control groups. National Collaborating Centre for Methods and Tools (NCCMT), 2009. http://www.nccmt.ca/pubs/non-RCT2_EN.pdf. Accessed September 10, 2014.
Poppelaars FA, Henneman L, Ader HJ, et al. Preconceptional cystic fibrosis carrier screening: attitudes and intentions of the target population. Genet Test. 2004; 8(2): 80-89.
Hegwer G, Fairley C, Charrow J, Ormond KE. Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program. J Genet Couns. 2006; 15(1): 61-70.
Ioannou L, Massie J, Collins V, McClaren B, Delatycki MB. Population-based genetic screening for cystic fibrosis: attitudes and outcomes. Public Health Genom. 2010; 13(7–8): 449-456.
Lakeman P, Plass AM, Henneman L, Bezemer PD, Cornel MC, ten Kate LP. Preconceptional ancestry-based carrier couple screening for cystic fibrosis and haemoglobinopathies: what determines the intention to participate or not and actual participation? Eur J Hum Genet. 2009; 17(8): 999-1009.
Maxwell SJ, Kyne G, Molster C, Barker NM, Ormsby J, O’Leary P. Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members. Genet Test Mol Biomark. 2011; 15(3): 159-164.
van Elderen T, Mutlu D, Karstanje J, Passchier J, Tibben A, Duivenvoorden HJ. Turkish female immigrants’ intentions to participate in preconception carrier screening for hemoglobinopathies in the Netherlands: an empirical study. Public Health Genom. 2010; 13(7–8): 415-423. doi:10.1159/000314643.
Weinreich SS, de Lange-de Klerk E, Rijmen F, Cornel M, de Kinderen M, Plass AM. Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers. BMC Public Health. 2009; 9(338): 1-9. doi:10.1186/1471-2458-9-338.
Widayanti CG, Ediati A, Tamam M, Faradz SM, Sistermans EA, Plass AM. Feasibility of preconception screening for thalassaemia in Indonesia: exploring the opinion of Javanese mothers. Ethn Health. 2011; 16(4/5): 483-499. doi:10.1080/13557858.2011.564607.
Di Lorio C. Measurement in health behavior: methods for research and evaluation. San Francisco: Jossey-Bass; 2005.